|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||5.00 - 5.28|
|52 Week Range||5.00 - 10.40|
|Beta (3Y Monthly)||-1.16|
|PE Ratio (TTM)||N/A|
|Earnings Date||Sep 21, 2017 - Sep 22, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||10.00|
If you’re interested in e-Therapeutics plc (LON:ETX), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact Read More...
LONDON, UK / ACCESSWIRE / April 23, 2018 / With the refocusing of the business and the new CEO's strategic review now implemented, e-Therapeutics (LSE: ETX) finds itself with the NDD platform and at least ...